Watch CBS News

How COVID vaccines are bulk manufactured

With $628 million from the U.S. government, Emergent Bio-Solutions in Baltimore is scaling up separate Johnson & Johnson and AstraZeneca COVID-19 vaccines, which are still pending FDA approval.
Nov 12, 2020 (03:26)
Videos
View CBS News In
CBS News App Open
Chrome Safari Continue